Dana M van der Heide1, Kiran K Turaga2, Carlos H F Chan1, Scott K Sherman3. 1. Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa. 2. Department of Surgery, University of Chicago, 5841 S Maryland Ave, Chicago, Illinois. 3. Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa. Electronic address: scott-sherman@uiowa.edu.
Abstract
BACKGROUND: Young adults with metastatic colorectal cancer (mCRC) may have higher rates of deficient mismatch repair (dMMR) than older patients. This study sought to assess patterns of MMR-testing and survival among young adult mCRC patients in the National Cancer Database (NCDB), hypothesizing that dMMR correlates with worse survival than in MMR-proficient (pMMR) patients. METHODS: Stage-IV colorectal cancers were identified in NCDB (2010-2016). Demographic and clinical features were compared between younger (age ≤ 30) and older mCRC patients and tested for association with overall survival. Stage-IV disease without other recorded metastatic sites defined peritoneal metastasis (PM). Fisher-exact tests compared proportions and Cox models tested association with overall survival. RESULTS: Of 124,587 stage-IV colorectal cancers, 1,123 (0.9%) were in young patients. Young patients were more likely to have mucinous histology, high-grade, rectal primaries, and isolated peritoneal metastases (P < 0.001). Younger patients more often had MMR-testing (29.1 versus 16.6%), with dMMR found at similar rates in young and older patients (21.7 versus 17.1% of those tested, P= 0.4). Despite higher rates of adverse prognostic features, younger patients had better survival (median 20.7 versus 14.8 months, P < 0.001). In MMR-tested patients, dMMR correlated with higher mortality risk compared to pMMR (median 16.6 months versus 25.5 months, P = 0.01). On multivariable analysis, grade and MMR-status remained independently associated with survival. CONCLUSIONS: Median survival was worse with dMMR by 8.9 months compared to pMMR in young adults with mCRC. Despite higher rates of familial syndromes in young patients and recommendations for universal MMR-testing, over 70% of young mCRC patients had no MMR-status recorded.
BACKGROUND: Young adults with metastatic colorectal cancer (mCRC) may have higher rates of deficient mismatch repair (dMMR) than older patients. This study sought to assess patterns of MMR-testing and survival among young adult mCRC patients in the National Cancer Database (NCDB), hypothesizing that dMMR correlates with worse survival than in MMR-proficient (pMMR) patients. METHODS: Stage-IV colorectal cancers were identified in NCDB (2010-2016). Demographic and clinical features were compared between younger (age ≤ 30) and older mCRC patients and tested for association with overall survival. Stage-IV disease without other recorded metastatic sites defined peritoneal metastasis (PM). Fisher-exact tests compared proportions and Cox models tested association with overall survival. RESULTS: Of 124,587 stage-IV colorectal cancers, 1,123 (0.9%) were in young patients. Young patients were more likely to have mucinous histology, high-grade, rectal primaries, and isolated peritoneal metastases (P < 0.001). Younger patients more often had MMR-testing (29.1 versus 16.6%), with dMMR found at similar rates in young and older patients (21.7 versus 17.1% of those tested, P= 0.4). Despite higher rates of adverse prognostic features, younger patients had better survival (median 20.7 versus 14.8 months, P < 0.001). In MMR-tested patients, dMMR correlated with higher mortality risk compared to pMMR (median 16.6 months versus 25.5 months, P = 0.01). On multivariable analysis, grade and MMR-status remained independently associated with survival. CONCLUSIONS: Median survival was worse with dMMR by 8.9 months compared to pMMR in young adults with mCRC. Despite higher rates of familial syndromes in young patients and recommendations for universal MMR-testing, over 70% of young mCRC patients had no MMR-status recorded.
Authors: Thierry André; Kai-Keen Shiu; Tae Won Kim; Benny Vittrup Jensen; Lars Henrik Jensen; Cornelis Punt; Denis Smith; Rocio Garcia-Carbonero; Manuel Benavides; Peter Gibbs; Christelle de la Fouchardiere; Fernando Rivera; Elena Elez; Johanna Bendell; Dung T Le; Takayuki Yoshino; Eric Van Cutsem; Ping Yang; Mohammed Z H Farooqui; Patricia Marinello; Luis A Diaz Journal: N Engl J Med Date: 2020-12-03 Impact factor: 91.245
Authors: Joanne P Young; Aung Ko Win; Christophe Rosty; Ingrid Flight; David Roder; Graeme P Young; Oliver Frank; Graeme K Suthers; Peter J Hewett; Andrew Ruszkiewicz; Ehud Hauben; Barbara-Ann Adelstein; Susan Parry; Amanda Townsend; Jennifer E Hardingham; Timothy J Price Journal: J Gastroenterol Hepatol Date: 2015-01 Impact factor: 4.029
Authors: Ben Tran; Scott Kopetz; Jeanne Tie; Peter Gibbs; Zhi-Qin Jiang; Christopher H Lieu; Atin Agarwal; Dipen M Maru; Oliver Sieber; Jayesh Desai Journal: Cancer Date: 2011-03-31 Impact factor: 6.860
Authors: Alberto Puccini; Heinz-Josef Lenz; John L Marshall; David Arguello; Derek Raghavan; W Michael Korn; Benjamin A Weinberg; Kelsey Poorman; Arielle L Heeke; Philip A Philip; Anthony F Shields; Richard M Goldberg; Mohamed E Salem Journal: Oncologist Date: 2018-07-17
Authors: Sabine Venderbosch; Iris D Nagtegaal; Tim S Maughan; Christopher G Smith; Jeremy P Cheadle; David Fisher; Richard Kaplan; Philip Quirke; Matthew T Seymour; Susan D Richman; Gerrit A Meijer; Bauke Ylstra; Danielle A M Heideman; Anton F J de Haan; Cornelis J A Punt; Miriam Koopman Journal: Clin Cancer Res Date: 2014-08-19 Impact factor: 12.531
Authors: Dung T Le; Tae Won Kim; Eric Van Cutsem; Ravit Geva; Dirk Jäger; Hiroki Hara; Matthew Burge; Bert O'Neil; Petr Kavan; Takayuki Yoshino; Rosine Guimbaud; Hiroya Taniguchi; Elena Elez; Salah-Eddin Al-Batran; Patrick M Boland; Todd Crocenzi; Chloe E Atreya; Yi Cui; Tong Dai; Patricia Marinello; Luis A Diaz; Thierry André Journal: J Clin Oncol Date: 2019-11-14 Impact factor: 44.544
Authors: G Emerens Wensink; Marloes A G Elferink; Anne M May; Linda Mol; Patricia A H Hamers; Sandra D Bakker; Geert-Jan Creemers; Jan Willem B de Groot; Gerty J de Klerk; Brigitte C M Haberkorn; Annebeth W Haringhuizen; Ronald Hoekstra; J Cornelis B Hunting; Emile D Kerver; Danielle Mathijssen-van Stein; Marco B Polée; Johannes F M Pruijt; Patricia Quarles van Ufford-Mannesse; Sandra Radema; Ronald C Rietbroek; Lieke H J Simkens; Bea C Tanis; Daan Ten Bokkel Huinink; Manuel L R Tjin-A-Ton; Cathrien S Tromp-van Driel; Monique M Troost; Agnes J van de Wouw; Franchette W P J van den Berkmortel; Anke J M van der Pas; Ankie M T van der Velden; Marjan A van Dijk; Joyce M van Dodewaard-de Jong; Edith B van Druten; Theo van Voorthuizen; Gerrit Jan Veldhuis; Henk M W Verheul; Hanneke J H M J Vestjens; Jeroen Vincent; Onno W Kranenburg; Cornelis J A Punt; Geraldine R Vink; Jeanine M L Roodhart; Miriam Koopman Journal: Br J Cancer Date: 2020-10-13 Impact factor: 7.640
Authors: Cong-Min Zhang; Jin-Feng Lv; Liang Gong; Lin-Yu Yu; Xiao-Ping Chen; Hong-Hao Zhou; Lan Fan Journal: Int J Environ Res Public Health Date: 2016-09-08 Impact factor: 3.390